Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery

US Patent 10934358 · Granted Mar 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating NETosis and neutrophil activation2025
Methods for treating NETosis and neutrophil activation2025
Antibody therapies and methods for treating coronavirus infection2023
Antibody therapies and methods for treating coronavirus infection2023
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and strok2022
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and strok2022
Polypeptide compositions and methods for site-specific targeting of therapeutic 2021
Polypeptide compositions and methods for site-specific targeting of therapeutic 2021
Methods for treating netosis and neutrophil activation2020
Methods for treating netosis and neutrophil activation2020
Theranostic compositions and uses thereof2020
Theranostic compositions and uses thereof2020